| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078209 Fused nitrogen heterocyclic compounds; treating fungal diseases |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | US7078040 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them |
| 07/18/2006 | CA2216592C Benzothiophene compounds, intermediates, compositions, and methods |
| 07/13/2006 | WO2006073729A1 Oral disintegrating dosage forms |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073181A1 Cell activator, cell death inhibitor and cell death promoter |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073147A1 Remedial agent for fat toxicity |
| 07/13/2006 | WO2006073042A1 ACTIVATOR FOR Nrf2-DEPENDENT GENE |
| 07/13/2006 | US20060154982 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases such as cancer, psoriasis, arteriosclerosis or is at risk of restenosis of the coronary arteries after vascular surgery |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154933 Inhibitors of Cdc25 phosphatases |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154892 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 07/13/2006 | US20060154876 Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 07/13/2006 | US20060154869 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060154339 Novel clock gene BMAL2 |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153848 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/13/2006 | US20060153801 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | CA2593768A1 Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity |
| 07/13/2006 | CA2593728A1 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
| 07/12/2006 | EP1679371A1 Method of evaluating cancerization degree |
| 07/12/2006 | EP1679370A1 Method of evaluating cancerization degree |
| 07/12/2006 | EP1679308A1 Novel indazole derivative |
| 07/12/2006 | EP1679296A1 Ether derivative |
| 07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 07/12/2006 | EP1679071A1 Collagen productin enhancer and production process and use thereof |
| 07/12/2006 | EP1679067A1 Concurrent drugs |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1467750B1 Orodispersible pharmaceutical composition comprising perindopril |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1289557B1 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor |
| 07/12/2006 | EP1263435B1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 07/12/2006 | EP1237559B1 Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
| 07/12/2006 | EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 07/12/2006 | EP1124950B1 Morpholino based p53 antisense oligonucleotide, and uses thereof |
| 07/12/2006 | EP1037645B1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/12/2006 | EP1015002B1 Aluminium free mixed metal compounds as phosphate binders |
| 07/12/2006 | EP0994719B1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
| 07/12/2006 | EP0876396B1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802377A Tricyclic compound |
| 07/12/2006 | CN1802175A Cells used as carriers for bacteria |
| 07/12/2006 | CN1800399A 磷酸二酯酶8a Phosphodiesterase 8a |
| 07/12/2006 | CN1800186A Adenosine a2a receptor antagonists |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/12/2006 | CN1800171A Podocarpus extract and its preparation method |
| 07/12/2006 | CN1799631A Animal model for fetal alcohol syndrome and methods of treatment |
| 07/12/2006 | CN1799629A Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 07/12/2006 | CN1799620A Healthcare wine and its preparation method |
| 07/12/2006 | CN1799591A Preparation method of 'Xue Fu Zhu Yu' capsule and quality standard thereof |
| 07/12/2006 | CN1799571A Medicine for lowering blood sugar and treating women menopausal syndrome and preparation method thereof |
| 07/12/2006 | CN1799569A Chinese medicinal soft capsule, its preparation process and quality control method |
| 07/12/2006 | CN1799561A Application of Antrodia camphorata mycelium fermented extract in preparation of anti-radiation damage medicine |
| 07/12/2006 | CN1799556A Anti-drowsiness aromatic agent |
| 07/12/2006 | CN1799538A Medicine capable of promoting height elevation and formulation thereof |
| 07/12/2006 | CN1799390A Method for preparing yin-nourishing health-preserving soybean milk liquor with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
| 07/12/2006 | CN1799389A Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
| 07/12/2006 | CN1799388A Method for preparing yin-nourishing health-preserving soybean milk powder with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian |
| 07/12/2006 | CN1799382A Method for preparing yin-nourishing health-preserving milk liquor with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomon |
| 07/12/2006 | CN1799381A Method for preparing yin-nourishing health-preserving soybean with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomonseal |
| 07/12/2006 | CN1799380A Method for preparing yin-nourishing health-preserving milk tablet with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomon |
| 07/12/2006 | CN1799379A Method for preparing yin-nourishing health-preserving soybean tablet with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solo |
| 07/12/2006 | CN1799376A Method for preparing yin-nourishing health-preserving yoghourt with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomonsea |
| 07/12/2006 | CN1799375A Method for preparing yin-nourishing health-preserving soybean yoghourt with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian so |
| 07/12/2006 | CN1263856C Operation of enzymatic vitality of protoporphyrinogen oxidase in eukaryote |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |